Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)
Clinical trial NCT02885610 · COMPLETED
Trial details
- NCT number
- NCT02885610
- Sponsor
- RemeGen Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2019-06-11
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.